Answer
In healthy adults aged 18–22 years, a robust immune response against all four serogroups (A, C, W-135 and Y) was observed as early as 7 days after a single dose of Menveo.
Sources for this answer
- Menveo Group A,C,W135 and Y conjugate vaccineGlaxoSmithKline UK · emc · SmPC §5.1 Pharmacodynamic properties · Version 16Document updated
Sources checked